Blood cancers, Myeloma, Non-Hodgkin lymphoma (NHL)
Results
Phase 1
This trial is looking at whether other drugs affect the way the body breaks down bortezomib (Velcade) in people with non Hodgkin lymphoma or myeloma that has continued to grow.
Recruitment start: 31 July 2007
Recruitment end: 18 December 2009
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Simon Rule
Johnson and Johnson Pharmaceutical R+D
Last reviewed: 17 December 2015
CRUK internal database number: 2501
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
